|

AI-based Measurements of Tumour Burden in PSMA PET-CT

RECRUITINGSponsored by Elin Tragardh
Actively Recruiting
SponsorElin Tragardh
Started2024-03-29
Est. completion2031-03
Eligibility
Age20 Years – 120 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT06363435

Summary

The primary aim of the present study is to evaluate how automatically calculated (by an AI-based method) tumour burden, measured as tumour volume (TV) and as tumour uptake (TU: TV x SUVmean) in the prostate/prostate bed, pelvic lymph nodes, distant lymph nodes, bone and as the total tumour burden predicts overall survival (OS) in patients with prostate cancer (newly diagnosed and patients with biochemical recurrence).

Eligibility

Age: 20 Years – 120 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria:

* Patients referred to a clinically indicated 18F-PSMA-1007 PET-CT scan at Skåne University Hospital, Lund or Malmö, Sweden

Exclusion Criteria:

* Patients under 20 years old

Conditions2

CancerProstate Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.